NEW YORK (GenomeWeb News) – German firm Analytik Jena today said it has acquired all remaining shares of its subsidiary AJ Roboscreen.
Analytik Jena said the deal will enable it to continue a focus on the reagents business, a growing segment in the life science space. Based in Leipzig, Germany, AJ Roboscreen develops, manufactures, and markets products and services for the purification and detection of nucleic acids and specific proteins. Its lead technology is called TripleHyb, a detection format for real-time PCR.
Analytik Jena is based in Jena, Germany, and sells bioanalytical instruments and kits.